Skip to content
What Causes What
MECHANISM? CONDITIONAL

Omega-3 supplementation → Depression

Higher Omega-3 supplementation moves Depression only in some conditions. Read the mechanism.

Lespérance 2011 found that 1,200 mg a day of EPA-heavy fish oil versus sunflower oil missed the primary Inventory of Depressive Symptomatology contrast among 432 Canadian outpatients in a major depressive episode (adjusted difference 1.32, -0.20 to 2.84); a planned no-anxiety slice moved, and two later pilots of 60 and 61 people do not settle the sign.

Randomized trial · Contested · N=432

Supported by an experiment or a tightly identified design. Read the caveats.

Mechanism

Authors treat EPA as an anti-inflammatory fat that might ease a depressive episode. They do not agree on dose, on whether anxiety has to be absent, or on whether C-reactive protein has to be high. Lespérance, Frasure-Smith, St-André and colleagues (2011) assigned 432 Canadian outpatients with a Mini-International major depressive episode lasting at least four weeks to 1,050 mg EPA plus 150 mg DHA a day or sunflower oil (2 percent fish oil) for eight weeks. 40.3 percent were already on an antidepressant. The primary self-report IDS-SR30 difference was 1.32 points (-0.20 to 2.84, P=0.088). Clinician MADRS sat at 0.97 (-0.012 to 1.95, P=0.053). A planned anxiety interaction was significant (P=0.035). In 204 people without a comorbid anxiety disorder the IDS difference was 3.17 (0.89 to 5.45). Wu, Yang, Liu and colleagues (2024) assigned 60 unmedicated Taiwanese adults with DSM major depression and HRSD-21 above 18 to 3.2 g a day (2.1 g EPA, 1.1 g DHA) or soybean oil for twelve weeks. Week-12 Hamilton means were 13.50 versus 18.53 (P=0.010). Response and remission did not differ. Between-group erythrocyte EPA and DHA also did not differ at week 12. Mischoulon, Dunlop, Kinkead and colleagues (2022) assigned 61 unmedicated overweight adults with MDD and hs-CRP at or above 3.0 mg per liter to 1, 2, or 4 g of EPA or placebo for twelve weeks. The prespecified endpoints were inflammatory. In 45 completers, 4 g response on IDS-C30 was 64 percent versus 40 percent on placebo (odds ratio 2.63; all P>0.05).

Caveats

Researchers assigned people to a capsule or a control, so this is a trial stamp. The main result in the only mid-size trial missed. More papers of the same design do not settle the claim. Lespérance is eight weeks, mixed treated and untreated, sunflower oil with a little fish oil as placebo. The no-anxiety slice was planned. It is still a slice. Wu is 60 people, 50 of them women, no other treatment allowed, and a mixed-model treatment-by-time P of 0.045. Categorical response and remission did not move. Red-cell EPA and DHA rose in both arms and did not differ between arms at week 12. Mischoulon is a 61-person dose-finding trial whose primary was inflammation, not mood. The 4 g depression response missed significance. It is not a stack, and it is not a reason to treat C-reactive protein with fish oil. None of these files is a grocery capsule in people who are not already depressed. This page is not the heart-event page. This is a journal entry, not medical advice and not a reason to start or stop a capsule.

Effect

qualitative. Lespérance 2011: IDS-SR30 MD 1.32 (-0.20 to 2.84), P=0.088, N=432. No-anxiety slice 3.17 (0.89-5.45). Wu 2024 HRSD week 12 13.50 vs 18.53, N=60. Mischoulon 4g response 64% vs 40%, P>0.05.

Nodes

Lifestyle & environmentOmega-3 supplementationPsychology & behaviorDepression

Named confounders

Cite this page

What Causes What. “Omega-3 supplementation → Depression.” https://whatcauseswhat.org/edges/e-omega3-depression (atlas updated 2026-09-02).

https://whatcauseswhat.org/edges/e-omega3-depression

Papers